Table 2.
Univariate and Multivariate analysis of FB, C3bBbP and TCC.
| FB | C3bBbP | TCC | ||||
|---|---|---|---|---|---|---|
| Uni | Multi | Uni | Multi | Uni | Multi | |
| Male sex | 0.07 | 0.19** | 0.19** | 0.02 | ||
| Age | 0.24** | 0.13* | -0.10 | 0.04 | ||
| BMI | -0.03 | 0.13* | 0.01 | |||
| Aetiology CAD | 0.15** | 0.00 | 0.03 | |||
| Duration HF | 0.17** | 0.04 | -0.03 | |||
| NYHA | 0.07 | -0.05 | -0.13* | -0.13* | ||
| DM | 0.07 | -0.08 | -0.02 | |||
| Hypertension | 0.09 | -0.08 | 0.02 | |||
| Previous MI | 0.11* | -0.01 | -0.03 | |||
| COPD | 0.01 | -0.02 | -0.02 | |||
| LVEF | 0.02 | -0.06 | 0.03 | |||
| WBC | -0.01 | 0.06 | 0.00 | |||
| eGFR | -0.52** | -0.38** | 0.17** | 0.14** | -0.04 | |
| Cholesterol | -0.30** | -0.20** | 0.03 | 0.01 | ||
| NT-proBNP | 0.37** | 0.17** | -0.18** | -0.14* | -0.04 | |
| CRP | 0.25** | 0.12* | 0.00 | 0.12* | 0.13* | |
Uni, univariate analysis; Multi, multivariate analysis; BMI, body mass index; CAD, coronary artery disease; HF, heart failure; NYHA, New York Heart Association functional class; NYHA, New York Heart Association functional class; MI, myocardial infarction; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; WBC, white blood cell; eGFR, estimated glomerular filtration rate; NT-proBNP, N-terminal pro–B-type natriuretic peptide; CRP, C-reactive protein. For multivariable analysis standardized beta is shown. *p<0.05, **p<0.005.